Alternatives Unit, Biomedical Primate Research Centre, Lange Kleiweg 161, 2288 GJ Rijswijk, The Netherlands.
CNS Neurol Disord Drug Targets. 2011 Feb;10(1):4-24. doi: 10.2174/187152711794488610.
Innate immune responses in the central nervous system must be tightly regulated as unrestrained activation generates a chronic inflammatory environment that can contribute to neurodegeneration and autoimmunity. Microglia express a wide variety of receptors of the innate immune system and are competent responders to danger. Toll-like receptor-, NOD-like receptor- and RIG1-like receptor-mediated activation of microglia leads to the production of pro-inflammatory cytokines and to the upregulation of molecules implicated in activation of the adaptive immune system. Activated microglia are a characteristic feature of many neuroinflammatory disorders and they represent an attractive therapeutic target. This review describes the mechanisms that are at play to restrain microglia activation under homeostatic conditions, such as CD172a, CD200R, SIGIRR and TREM2-mediated signaling, as well as dynamic inhibitory mechanisms that are at play during inflammatory conditions, such as adenosine receptor-mediated signaling. In addition, intracellular activating and inhibitory signaling cascades are summarized in detail and their therapeutic potential is analyzed.
中枢神经系统的固有免疫反应必须受到严格的调控,因为不受控制的激活会产生慢性炎症环境,从而导致神经退行性变和自身免疫。小胶质细胞表达多种固有免疫系统的受体,并且能够对危险作出反应。Toll 样受体、NOD 样受体和 RIG1 样受体介导的小胶质细胞激活导致促炎细胞因子的产生,并上调与适应性免疫系统激活有关的分子。活化的小胶质细胞是许多神经炎症性疾病的特征,它们是一个有吸引力的治疗靶点。本综述描述了在稳态条件下抑制小胶质细胞激活的机制,如 CD172a、CD200R、SIGIRR 和 TREM2 介导的信号转导,以及在炎症条件下发挥作用的动态抑制机制,如腺苷受体介导的信号转导。此外,还详细总结了细胞内激活和抑制信号级联,并分析了它们的治疗潜力。